医学
热烧蚀
甲状腺结节
放射科
烧蚀
协商一致会议
梅德林
医学物理学
甲状腺
普通外科
作者
Shi-liang Cao,Bozhao Wang,Jae‐Joong Kim,Gregory W. Randolph,Song-Yuan Yu,Giovanni Mauri,Wei-Che Lin,Gang Dong,Kai‐Lun Cheng,Bülent Çekiç,Song-Song Wu,Ingo Janssen,Hossam Arafa Ghazi,Jian-Qin Guo,Gerardo Amabile,Carlos Neutzling Lehn,Junfeng He,Rafael D. Cicco,Eveline Slotema,BO-QIANG FAN
标识
DOI:10.1097/js9.0000000000004824
摘要
BACKGROUND: In recent decades, thermal ablation (TA) has gained acceptance as an effective and safe treatment for benign thyroid nodules (BTNs). However, despite its increasing popularity, the indications and techniques of TA for BTNs lack a unified standard, resulting in differences in treatment outcomes. In particular, the current guidelines and consensus statements adopt indications based on surgical criteria, which focus on larger BTNs with symptoms or cosmetic concerns. However, these indications may not adequately demonstrate the advantages of TA, as it is a fundamentally distinct therapeutic approach. To establish novel and specific indications for TA in BTNs and to standardize the use of this technique, a panel of experts issued the current expert consensus. MATERIALS AND METHODS: Based on a systematic review of the literature and clinical experience, the drafting group developed preliminary recommendations on TA for BTNs. A multidisciplinary panel of 30 experts with specific competence and expertise in TA for thyroid nodules reviewed, rated, and revised these recommendations through multiple rounds of the modified Delphi method. RESULTS: Twenty-six recommendations on TA for BTNs were proposed in the present consensus, covering indications and contraindications, physician training suggestions, preablation preparation, technical procedures, complications, efficacy assessment, follow-up strategies, and postablation management. CONCLUSION: The present consensus emphasizes the indication of TA for BTNs and outlined the technique details and periablation management. The implementation of this consensus is expected to standardize treatment practices, enhance patient outcomes, and shape future research and policy developments in the management of BTNs.
科研通智能强力驱动
Strongly Powered by AbleSci AI